Conversely, inhibiting HMMR-AS1 not only diminishes these processes but also increases GBM cell radiosensitivity by altering DNA repair proteins, positioning HMMR-AS1 as a promising target for GBM therapy. Here, HMMR is linked to glioblastoma.